Literature DB >> 2501260

Analysis of the relationship between defective sperm function and the generation of reactive oxygen species in cases of oligozoospermia.

R J Aitken1, J S Clarkson, T B Hargreave, D S Irvine, F C Wu.   

Abstract

The ability of human spermatozoa to exhibit sperm-oocyte fusion in response to the ionophore, A23187, was examined in relation to the capacity of these cells to generate reactive oxygen species. In 70 fertile control donors, there was an overwhelming pattern of high levels of sperm-oocyte fusion associated with low levels of reactive oxygen species production. By contrast, 88% of the 74 oligozoospermic patients exhibited less than 25% oocyte penetration in response to A23187 and 58% exhibited no penetration whatsoever. Of the 40 oligozoospermic patients who failed to respond to A23187, nine had low levels of reactive oxygen species production in association with impaired liquefaction of seminal plasma. Of the remainder, 17 (55%) exhibited defective sperm function together with elevated production of reactive oxygen species. These observations, which are the first to describe a biochemical defect in the spermatozoa of oligozoospermic patients, may carry significant implications for the etiology and treatment of this condition.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2501260     DOI: 10.1002/j.1939-4640.1989.tb00091.x

Source DB:  PubMed          Journal:  J Androl        ISSN: 0196-3635


  27 in total

1.  Leukocytes and oxidative stress: dilemma for sperm function and male fertility.

Authors:  Ralf R Henkel
Journal:  Asian J Androl       Date:  2010-11-15       Impact factor: 3.285

2.  The effects of oxidative stress on outcomes of assisted reproductive techniques.

Authors:  Ozay Oral; Tayfun Kutlu; Evrim Aksoy; Cem Fiçicioğlu; Hüsamettin Uslu; Semih Tuğrul
Journal:  J Assist Reprod Genet       Date:  2006-01-04       Impact factor: 3.412

3.  An evaluation of the effect of pentoxifylline on sperm function and treatment outcome of male-factor infertility: a preliminary study.

Authors:  S Fountain; B Rizk; S Avery; C Palmer; M Blayney; M Macnamee; C Mills; P Brinsden
Journal:  J Assist Reprod Genet       Date:  1995-11       Impact factor: 3.412

4.  Isolation of motile spermatozoa: comparison of Percoll centrifugation, SpermPrep filtration, and swim-up techniques.

Authors:  S Ziebe; C Y Andersen
Journal:  J Assist Reprod Genet       Date:  1993-10       Impact factor: 3.412

5.  The significance of testicular reactive oxygen species on testicular histology in infertile patients.

Authors:  T Soygür; E Yilmaz; S Elgün; A Keskineğe; O Göğüş
Journal:  Int Urol Nephrol       Date:  1999       Impact factor: 2.370

6.  Selenium-vitamin E supplementation in infertile men. Effects on semen parameters and micronutrient levels and distribution.

Authors:  D Vézina; F Mauffette; K D Roberts; G Bleau
Journal:  Biol Trace Elem Res       Date:  1996       Impact factor: 3.738

7.  Cistanoside of Cistanche Herba ameliorates hypoxia-induced male reproductive damage via suppression of oxidative stress.

Authors:  Fengqi Yan; Xiaoliang Dou; Guangfeng Zhu; Mingyuan Xia; Yahui Liu; Xiaozi Liu; Guojun Wu; He Wang; Bo Zhang; Qiuju Shao; Yong Wang
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

8.  Glass wool filtration reduces reactive oxygen species by elimination of leukocytes in oligozoospermic patients with leukocytospermia.

Authors:  R Sánchez; M Concha; T Ichikawa; R Henkel; W B Schill
Journal:  J Assist Reprod Genet       Date:  1996-07       Impact factor: 3.412

9.  Lycopene therapy in idiopathic male infertility--a preliminary report.

Authors:  Narmada P Gupta; Rajeev Kumar
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

10.  Rapid measurement of 8-oxo-7,8-dihydro-2'-deoxyguanosine in human biological matrices using ultra-high-performance liquid chromatography-tandem mass spectrometry.

Authors:  Patricia M W Lam; Vilas Mistry; Timothy H Marczylo; Justin C Konje; Mark D Evans; Marcus S Cooke
Journal:  Free Radic Biol Med       Date:  2012-04-15       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.